Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Boosted by State of Alaska Department of Revenue

State of Alaska Department of Revenue grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% in the first quarter, according to its most recent filing with the SEC. The fund owned 41,789 shares of the medical equipment provider’s stock after acquiring an additional 1,170 shares during the period. State of Alaska Department of Revenue’s holdings in Intuitive Surgical were worth $20,696,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $26,000. Global Financial Private Client LLC lifted its holdings in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares in the last quarter. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Finally, Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 216 shares of the firm’s stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president now owns 907 shares of the company’s stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,998 shares of company stock worth $2,611,577. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $512.11 on Wednesday. The company has a market cap of $183.55 billion, a P/E ratio of 75.09, a P/E/G ratio of 5.51 and a beta of 1.67. The stock’s 50-day moving average is $527.58 and its 200-day moving average is $538.12. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the company earned $1.50 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ISRG shares. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Piper Sandler reduced their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Robert W. Baird cut their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.